Ignite Creation Date:
2024-05-05 @ 9:30 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00891228
Status:
COMPLETED
Last Update Posted:
2018-05-24
First Post:
2009-04-30
Brief Title:
Study of the Safety and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men
Sponsor:
Health Decisions
Organization:
Health Decisions
Study Overview
Official Title:
A Multicenter Randomized Double-Blind Comparator Trial of the Safety and Sperm and Gonadotropin Suppression Resulting From Combined Use of Nestorone Gel 0 8 or 12 mg NES and Testosterone Gel 10 g Compared With Testosterone Gel in Normal Men
Status:
COMPLETED
Status Verified Date:
2018-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CCN007
Brief Summary:
To determine the number of men who have suppression of sperm production when using a daily regimen of Nestorone Gel 0 8 or 12 mg and Testosterone Gel applied transdermally
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None